CD BioGlyco is a world-leading company that provides the best solutions for global customers in the field of microarrays. We have successfully developed many Glycobiology Arrays and corresponding testing services to accelerate the high-throughput detection of glycosylated proteins in biological samples. Glycome array is one kind of them. We guarantee to provide first-class array screening service to customers all over the world.
The glycosylation array prints the capture antibody (the glycosylation of the capture antibody has been removed) on a glass slide, allowing researchers to quickly and effectively obtain the glycosylation curve in the sample. The detection principle of our slide array is similar to the sandwich method. The pre-blocked slide array is hybridized with the sample and washed to remove unbound proteins. The biotin-labeled lectin is then incubated with the array to bind to the glycan of the captured target protein and then labeled with a streptavidin-conjugated fluorescent dye. Finally, laser fluorescence scanning is used to visualize the signal to identify glycoproteins present in the sample. Biological samples from experimental subjects contain complex glycosylation-modified protein components. How to obtain glycosylated protein profiles of samples quickly and efficiently has become the focus of scientific researchers. In high-throughput analysis methods, compared to methods that can resolve detailed structures such as mass spectrometry, arrays have many advantages, such as a small sample size, no expensive equipment, and a short detection cycle.
Our glycome array can be used in a variety of situations, including identifying and analyzing glycans in a sample, determining whether a biomarker of interest to researchers has a glycan moiety, and determining its relative expression level. These products can only be used to test human and laboratory animal samples in non-clinical studies. The detection targets of glycome array include but are not limited to cytokines, chemokines, adipokines, growth factors, angiogenic factors, proteases, soluble receptors, and soluble adhesion from cell culture supernatants, serum, plasma, and sample lysates molecular. If you have other interesting combinations, you can also choose to upload the designed target set, and we will customize the array of products for you.
CD BioGlyco provides high-quality array screening services for the rapid detection of glycosylated proteins. We provide commercialized arrays and customized array services for glycomics analysis according to your research goals. With a large team of scientists and a well-equipped array production platform and testing experiment platform, we provide a comprehensive combination of laboratories and manufacturing services. We have comprehensive capabilities and are committed to working with customers all over the world to meet your specific requirements. Please contact us for more details.
|Cat. No.||Product Name||Inquiry|
|CMA-1000||Human Glycosylation Array-1000|
|CMA-2000||Human Glycosylation Array-2000|
|CMA-500||Human Glycosylation Array-500|
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.